Diabetes & Endocrinology News

Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
Medscape Medical News, December 04, 2023
Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
Medscape Medical News, December 04, 2023
No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
Medscape Medical News, December 04, 2023
How Gender-Affirming Treatment Affects Erythrocytosis Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.
Medscape Medical News, December 04, 2023
US Obesity Docs Expect Zepbound to Show Heart Benefit Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
Reuters Health Information, December 01, 2023
Launches of Novo Nordisk's Weight-Loss Drug Wegovy Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe and Asia, even as it struggles to keep up with demand.
Reuters Health Information, December 01, 2023
EU Watchdog Seeks More Safety Data From GLP-1 Drugmakers The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them.
Reuters Health Information, December 01, 2023
Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting.
Reuters Health Information, December 01, 2023
Smoking Alters Salivary Microbiota Changes in oral microbiota caused by cigarette smoking could contribute to development of chronic health conditions.
Medscape Medical News, December 04, 2023
Procedures May Ease Postmenopausal Pain Better Than Drugs Postmenopausal women report more significant improvements in chronic pain after procedural interventions when compared with their younger counterparts, despite being notably less likely to use muscle relaxants, TCAs, and benzodiazepines.
Medscape Medical News, December 01, 2023
AI Aids Type 2 Diabetes Insulin Dosing A patient-facing voice-based conversational artificial intelligence application helped patients with type 2 diabetes optimize their insulin doses.
Medscape Medical News, December 01, 2023
What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
Medscape Medical News, December 01, 2023
Novo Nordisk Finds Compounded Wegovy Up to 33% Impure Novo Nordisk on Thursday said it sued one compounding pharmacy and refiled a lawsuit against another after finding their products claiming to contain the active ingredient for its in-demand weight-loss drug were impure.
Reuters Health Information, November 30, 2023
Late-Life Increases in Pulmonary Pressure, Hypertension Age-related increases in pulmonary artery systolic pressure occur in concert with worsening left ventricular diastolic dysfunction and contribute to late-life dyspnea, new data show.
Medscape Medical News, November 30, 2023
ACG 2023 Low-Dose Aspirin: No Flares in Pregnant Patients With IBD Low-dose aspirin is recommended for pregnant women who are at risk of hypertensive disorders, such as eclampsia, preeclampsia, and gestational diabetes.
MDedge News, November 29, 2023
DMARDs Linked to Reduced Thyroid Disease Incidence In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs the general population, with the effect strongest among those treated with anti-rheumatic drugs.
Medscape Medical News, November 29, 2023
Insufficient Sleep Impairs Women's Insulin Sensitivity Restricted sleep of around 6 hours per night may be enough of a reduction to increase the risk for impaired insulin sensitivity in women, particularly if they are postmenopausal, suggests a US trial.
Medscape Medical News, November 28, 2023
More Weight Loss With Mounjaro Than Ozempic: Data Analysis Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly's Mounjaro than those taking Novo Nordisk's popular rival weight loss drug.
Reuters Health Information, November 27, 2023
AANEM 2023 Novel Myasthenia Gravis Therapies Bring Opportunities New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.
MDedge News, November 27, 2023
Despite Effective Therapies, Fibroid Care Still Lacking Minimally invasive procedures for uterine fibroids are highly effective, but gaps in diagnosis, racial disparities, and lack of availability outside urban academic centers limit their use.
Medscape Medical News, November 27, 2023
Novo to Launch Wegovy in Asia With February Roll-Out in Japan Novo Nordisk will launch its hugely popular anti-obesity drug in Japan on February 22, its first launch in Asia, even as it struggles to keep up with demand in existing markets.
Reuters Health Information, November 23, 2023
Novo Invests $2.3 Billion in France for Obesity Drug Production Novo Nordisk has announced a $2.3 billion investment to boost production of its wildly popular weight-loss and diabetes drugs at a site in Chartres, France.
Reuters Health Information, November 23, 2023
Cyberattacks Challenge Canadian Health Information Systems A new analysis recommends a four-stage plan for physicians and health systems to improve their cybersecurity practices.
Medscape Medical News, November 27, 2023
Urine Test Identifies Endocrine Hypertension With Help From AI The test uses machine learning to assess the likelihood that a person’s hypertension is secondary to cortisol and aldosterone excess.
Medscape News UK, November 16, 2023
Should Physicians Go to Work When Sick? Although most doctors believe it's best to stay home if they're ill, today's healthcare system makes the answer much more complicated.
Medscape Medical News, November 13, 2023
Even an Hour's Walk a Week Lowers Risk in Type 2 Diabetes Leisure time activity equivalent to less than 1.5 hours' walking time per week may be enough to substantially reduce the risk for neuropathy and nephropathy in type 2 diabetes, say Danish researchers.
Medscape Medical News, August 29, 2023
Both Too Much and Not Enough Sleep Raises T2D Risk Sleeping 3 or more hours over or under the average sleep duration of 8 hours increases the risk for type 2 diabetes, regardless of other factors, indicates Dutch study analysis.
Medscape Medical News, August 28, 2023
Apple Cider Vinegar, Fenugreek Best Herbal Remedies for T2D A new analysis found some herbal remedies including apple cider vinegar and fenugreek seeds are better than others at helping to manage type 2 diabetes.
Medscape Medical News, August 25, 2023
Jury Still Out on Stopping GLP-1 RAs Prior to Endoscopy Five professional gastroenterology organizations caution that more data are needed to understand if and when GLP-1 receptor agonists should be held prior to elective endoscopy.
Medscape Medical News, August 24, 2023
UK's First Living Donor Uterus Transplant a Success After 25 years' preclinical research, a British surgical team reported the UK's first living donor uterus transplant, with both donor and recipient doing well 10 weeks post-operatively.
Medscape News UK, August 23, 2023
As MOC Debate Heats Up, Cardiology Societies Weigh In The MOC process is once again under attack by cardiologists and other specialty physicians. A petition aiming to end the requirements has garnered more than 17,000 and counting signatures.
Medscape Medical News, August 22, 2023
Artificial Sweeteners Increase Cardiovascular Risk A recent scientific review confirms that artificial sweeteners affect primary cardiovascular risk factors.
Medscape Medical News, August 22, 2023
Firefighters Fight Fat With Mediterranean Diet Adoption A communal approach to adopting the Mediterranean diet lowered firefighters' risks for cardiovascular disease and cancer and improved their dietary adherence, both at home and work.
Medscape Medical News, August 18, 2023
A1c Not Linked to Postop Complications in Kids With Diabetes Findings suggest no need to delay elective surgery in order to optimize glycemic control in children with type 1 or type 2 diabetes.
Medscape Medical News, August 10, 2023
Biosimilars Comparable to Aflibercept in Macular Disease Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity.
Medscape Medical News, August 03, 2023
Only 1 in 4 Feel Fully Recovered Following COVID-19 Hospitalisation Being female, obese, and having had mechanical ventilation in hospital are all associated with being less likely to feel fully recovered one year after COVID-19 hospitalisation.
Medscape News UK, April 26, 2022
Call for Tighter LDL Targets for Highest Risk Patients With multiple new lipid-lowering drugs coming on the market, and European guidelines suggesting lower than ever targets in patients with very high cardiovascular risk, experts say aim for ‘ones not twos’ with low-density lipoprotein (LDL) targets.
Medscape News UK, November 15, 2021

No Results